CGON · ISSUER CIK 1991792
CG Oncology, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 CG Oncology, Inc. insiders reported $0.00 of open-market purchases and $210K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 3 of 3 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$210KInsider selling
−$210KNet open-market
Oct 19, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 202616:30 | Oct 15, 2026 | CGON | Director | S · Sell10b5-1 | $62.07 | −1,000 | 0 | -100% | −$62K | ||
| Oct 19, 202616:30 | Oct 15, 2026 | CGON | Director | M · Exercise10b5-1 | $0.60 | +1,000 | 1,000 | New | $600.00 | ||
| Sep 17, 202616:30 | Sep 15, 2026 | CGON | Director | S · Sell10b5-1 | $72.98 | −1,000 | 0 | -100% | −$73K | ||
| Sep 17, 202616:30 | Sep 15, 2026 | CGON | Director | M · Exercise10b5-1 | $0.60 | +1,000 | 1,000 | New | $600.00 | ||
| Aug 18, 202616:30 | Aug 14, 2026 | CGON | Director | S · Sell10b5-1 | $74.54 | −1,000 | 0 | -100% | −$75K | ||
| Aug 18, 202616:30 | Aug 14, 2026 | CGON | Director | M · Exercise10b5-1 | $0.60 | +1,000 | 1,000 | New | $600.00 |